Healthy volunteers test new combo pill for diabetes
NCT ID NCT07304726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how a new combination diabetes drug, CKD-383, is processed by the body and whether it is safe. Thirty healthy adults took the drug as two tablets together or separately in a random order. The goal was to compare the two ways of taking the medication. Since this was a Phase 1 trial in healthy people, it does not test if the drug works for diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?